Researchers found that the gum bacterium P. gingivalis can migrate to the heart, promoting atrial fibrosis and increasing atrial fibrillation risk, linking oral health directly to cardiovascular disease.
Most Recent Articles
Association Between Lipoprotein(a) Levels and Recurrent ASCVD Risk in a Large Cohort: The Impact of LDL-C Lowering Therapies
Elevated lipoprotein(a) levels were linked to higher recurrence risk in a cohort of over 270,000 ASCVD patients. Still, high-impact LDL-lowering therapies helped reduce this risk, highlighting the need for tailored interventions.
Efficacy of Obicetrapib in Reducing LDL Cholesterol and Lp(a) in High-Risk Cardiovascular Patients: BROADWAY Trial Results
The BROADWAY trial shows that obicetrapib significantly lowers LDL cholesterol and Lp(a) in high-risk cardiovascular patients, offering a safe and effective option beyond current lipid-lowering therapies.
VISUALIZED: Evolocumab Reduces Coronary Plaque Inflammation and Volume in CAD Patients
Read further: Evolocumab Reduces Coronary Plaque Inflammation and Volume in CAD Patients
Regional Differences in Burnout Among U.S. Internal Medicine Physicians
Burnout affects internal medicine physicians across all practice settings. Still, regional differences—especially higher rates in the Western U.S.—highlight the need for location-specific strategies to support clinician well...